The seminal papers reporting TPMs in melanoma pointed at an ETS-mediated role on TERT mutant promoter control [2,3], but the identification of the specific factors involved in this regulation, particularly in thyroid cancers, has proven not to be straightforward. This evidence concerns the gene TERT and thyroid gland carcinoma.